About Toujeo SoloStar 300 Units/ml 1.5ml
Toujeo SoloStar is a long acting basal insulin glargine U300 pen used to control blood sugar in diabetes.
Toujeo SoloStar 300 Units/ml 1.5ml Prefilled Pen Uses
- Long term blood sugar control in adults with type 1 diabetes mellitus
- Long term blood sugar control in adults with type 2 diabetes mellitus
- Basal (background) insulin component of a multiple daily injection insulin plan
- Once daily basal insulin for patients who need a steady, long acting glucose lowering effect
- Used alongside diet, exercise and other diabetes medicines as prescribed
Toujeo SoloStar 300 Units/ml 1.5ml Prefilled Pen Benefits
- Smooth, relatively peakless glucose lowering profile over 24 hours
- Action can extend up to 36 hours, giving some flexibility in injection timing
- Once daily dosing at the same time each day
- Prefilled pen delivers 1 to 80 units in 1 unit steps, no separate vial or syringe needed
- Associated with fewer nighttime hypoglycemia episodes than older U100 glargine in clinical trials
- Ready to use pen is convenient for patients who travel or work outside the home
What Experts Say
Pakistan carries one of the highest burdens of diabetes in the world, with millions of adults living with type 2 diabetes and a smaller but significant population with type 1 diabetes needing lifelong insulin. Many eventually need a basal insulin that keeps blood sugar steady overnight and between meals.
Insulin glargine U300 forms a small depot under the skin that releases insulin more slowly and evenly than the older U100 formulation. This flatter profile is why one daily Toujeo dose can cover a full 24 to 36 hour period. Trial data comparing U300 with U100 glargine show fewer nighttime hypoglycemia episodes, an important safety benefit for home use.
Because 1 ml of Toujeo holds 300 units instead of the usual 100, endocrinologists across Pakistan stress that doses cannot be copied directly from another insulin. Every switch needs individual recalculation, closer glucose monitoring, and a written plan from a qualified doctor.
Drug Class
- Long acting basal insulin analog
- Antidiabetic agent
Toujeo SoloStar 300 Units/ml 1.5ml Prefilled Pen Uses in Urdu
- ٹائپ 1 ذیابیطس کے مریضوں میں طویل مدتی بلڈ شوگر کنٹرول کے لیے
- ٹائپ 2 ذیابیطس کے مریضوں میں طویل مدتی بلڈ شوگر کنٹرول کے لیے
- دن میں ایک بار لگائی جانے والی بنیادی (بیسل) انسولین کے طور پر
- دیگر انسولین یا ذیابیطس کی گولیوں کے ساتھ مکمل علاج کے منصوبے میں
- خوراک اور ورزش کے ساتھ ساتھ شوگر کو مستحکم رکھنے کے لیے
Toujeo SoloStar 300 Units/ml 1.5ml formula
How to use Toujeo SoloStar 300 Units/ml 1.5ml?
- Inject Toujeo SoloStar under the skin (subcutaneously) once daily, at the same time every day, exactly as prescribed by a doctor
- Inject into the abdomen, thigh or upper arm, rotating the site with each injection to prevent skin changes
- Dial the prescribed dose on the pen before each injection and confirm the dose counter shows zero after the full dose is delivered
- Use the Toujeo SoloStar pen only for the person it was prescribed for and only with a new needle each time
- Never draw insulin out of the pen with a syringe for injection
- The starting dose and any later dose change must always be set by a doctor, since Toujeo U300 is three times more concentrated than standard U100 insulin and is never converted unit for unit by the patient
- Do not skip or double a missed dose without medical advice, contact a doctor for guidance
- Check blood sugar as advised by the treating doctor to confirm the dose is working correctly
Drug Interactions
- Oral Hypoglycemic Agents And Other Insulins: Combining these with Toujeo raises the risk of significant hypoglycemia and usually needs dose adjustment
- Beta Blockers: Medicines like propranolol or atenolol can mask common warning signs of hypoglycemia such as a fast heartbeat
- Corticosteroids: Steroid medicines raise blood glucose and can reduce how well Toujeo controls blood sugar
- Alcohol: Drinking alcohol can increase the risk of low blood sugar and hide its warning symptoms
- ACE Inhibitors And MAOIs: These can increase the blood sugar lowering effect of insulin and raise hypoglycemia risk
- Thiazide Diuretics And Thyroid Hormones: These can reduce the effect of Toujeo, sometimes raising blood sugar
- Pioglitazone And Other TZDs: Using these with insulin can increase the risk of fluid retention and heart failure
Risks and warnings
- Hypoglycemia: Toujeo can lower blood sugar too much, causing shakiness, sweating, confusion or fainting, so a fast acting sugar source should always be nearby
- U300 To U100 Conversion Risk: The dose must never be self converted from Lantus, NPH or any other insulin, since Toujeo is three times more concentrated and a unit for unit switch can cause serious over dosing or under dosing
- Never Share The Pen: A Toujeo SoloStar pen must never be shared with another person, even after changing the needle, due to the risk of spreading blood borne infections
- Injection Site Rotation: Always rotate injection sites within the abdomen, thigh or upper arm, repeated use of the same spot can cause lumps or uneven insulin absorption
- Not For Emergency Use: Toujeo is not intended to treat diabetic ketoacidosis and should not be used during an active hypoglycemic episode
- Kidney Or Liver Disease: Dose requirements may change in patients with kidney or liver impairment, closer monitoring is needed
- Pregnancy And Breastfeeding: Use only under direct medical supervision, since insulin needs often change during pregnancy
Toujeo SoloStar 300 Units/ml 1.5ml Prefilled Pen Side Effects
- Low blood sugar (hypoglycemia)
- Redness, swelling, itching or pain at the injection site
- Weight gain
- Mild fluid retention or swelling in the hands, ankles or feet
- Skin thickening or pitting (lipodystrophy) with repeated injections at the same site
- Allergic skin reactions such as rash or hives
- Low potassium levels in the blood
- Rare but serious whole body allergic reaction with swelling of the face, lips or throat and difficulty breathing
Storage Conditions
- Store unopened Toujeo SoloStar pens in a refrigerator between 2°C and 8°C until the expiry date
- Once a pen is in use, store it at room temperature below 30°C and away from direct heat or sunlight
- Discard an in use pen 56 days after the first injection, even if insulin remains inside
- Never freeze Toujeo, discard the pen immediately if it has been frozen
- Always keep the pen cap on when not in use to protect it from light
- Remove the needle after each injection and do not store the pen with a needle attached